Status:
COMPLETED
One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
Lead Sponsor:
Glaukos Corporation
Conditions:
Primary Open Angle Glaucoma (POAG)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of the intraocular pressure (IOP) lowering effect of one, two, or three iStent devices in eyes of subjects previously on two anti-glauc...
Eligibility Criteria
Inclusion
- Diagnosed with primary open-angle glaucoma (POAG)
- Subject on two topical hypotensive medications
Exclusion
- Traumatic, uveitic, neovascular, or angle closure glaucoma
- Fellow eye already enrolled
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2019
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT01517477
Start Date
January 1 2012
End Date
October 18 2019
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayan's Ophthalmology Centre
Yerevan, Armenia, 375108